Member story
Lost 14 kg in 5 months. But more importantly, my HbA1c went from 6.1 to 5.4.
Your endocrinologist reads fasting insulin, HOMA-IR, thyroid, testosterone, lipids, and HbA1c — then prescribes brand GLP-1 (Wegovy, Rybelsus — never compounded) only if clinically indicated. Baseline labs and 12-week follow-up are non-negotiable.
Every panel includes a 15–20 minute video consult with a specialist — read against South Asian-calibrated ranges. The AI works invisibly. The doctor does the medicine.
Ozempic and other GLP-1 medications are in explosive demand. But most people in India are buying them without proper baseline testing, physician consultation, or safety monitoring. This is both illegal and dangerous.
These biomarkers reveal the root causes — and what actually works to fix them.
Three steps. Your data. Your physician. Your protocol.
100+ biomarkers drawn at your door in 10 minutes. NABL-accredited labs. Results in 5 days. No clinic visit, no waiting rooms — just data.
Your physician reviews metabolic markers — insulin, thyroid, cortisol, leptin — and identifies what's actually preventing weight loss. Data, not guesswork.
GLP-1 therapy if appropriate, metabolic optimisation, hormonal correction, and dietary protocol — built on your bloodwork, not a template. Delivered in 48h.
Weight loss resistance is rarely about willpower. Thyroid dysfunction, insulin resistance, high cortisol, low testosterone, and inflammation all block fat loss.
Test your metabolic panel before starting another diet. If HbA1c is above 5.4%, fasting insulin above 12, or TSH above 2.5—address those first.
Identify which metabolic dysfunction is preventing fat loss in your body
| Cause | Key Biomarkers | Signs & Symptoms | Treatment Approach | Timeline |
|---|---|---|---|---|
| Insulin Resistance | Fasting insulin >12 mIU/L HbA1c >5.4% HOMA-IR >2.5 |
Sugar cravings, fatigue after meals, abdominal fat gain, PCOS | Metformin 500–1500mg daily, inositol, berberine, GLP-1 therapy, low glycemic diet | 8–12 weeks |
| Thyroid Dysfunction | TSH >2.5 mIU/L Free T4 low normal Free T3 <2.8 pg/mL |
Fatigue, cold intolerance, hair loss, dry skin, weight plateaus | Levothyroxine or NDT dosing, selenium, iodine, zinc optimization | 6–8 weeks |
| High Cortisol | 24h urine cortisol elevated Midnight salivary cortisol >4.0 nmol/L Evening cortisol >10 µg/dL |
Stress-related weight gain, belly fat, sleep disruption, mood swings | Sleep optimization, adaptogenic herbs (ashwagandha, rhodiola), stress management, cortisol-reducing diet | 8–16 weeks |
| Low Testosterone | Total T <400 ng/dL Free T <6.5 pg/mL SHBG elevated or low |
Muscle loss, fatigue, low libido, depression, weight gain despite diet | TRT or SERM therapy (clomiphene), resistance training, zinc & magnesium optimization | 8–12 weeks |
| Inflammation | hsCRP >3.0 mg/L TNF-α elevated IL-6 elevated |
Joint pain, bloating, brain fog, recurrent infections, slow recovery | Anti-inflammatory diet (omega-3, polyphenols), supplement with curcumin or omega-3s, GLP-1 as anti-inflammatory | 6–12 weeks |
| Leptin Resistance | Leptin >10 ng/mL Elevated triglycerides hsCRP elevated |
Constant hunger, inability to feel satiety, reduced response to fullness cues | GLP-1 therapy (restores leptin signaling), fasting periods, omega-3s, weight loss of 5–10% to reset leptin | 12–20 weeks |
Why treating root causes outperforms restriction
| Dimension | Calorie Counting Alone | Biomarker-Guided Protocol |
|---|---|---|
| Approach | Count calories, restrict intake, ignore metabolic dysfunction | Test 100+ biomarkers, identify blockers, treat root causes |
| Tests Required | None (or minimal) | HbA1c, fasting insulin, TSH, cortisol, leptin, lipids, inflammation markers |
| Success Rate (1 year) | 15–25% sustain weight loss | 60–75% achieve & maintain goals |
| Sustainability | Low—hunger, fatigue, metabolic adaptation | High—biomarkers normalize, hunger signals reset, energy improves |
| Addresses Root Cause? | No—ignores metabolic dysfunction | Yes—fixes thyroid, insulin, cortisol, hormones |
| Example Protocol | "Eat 1500 kcal/day. Walk daily. Motivation = success." | "HbA1c 5.7, insulin 14, TSH 3.2—start GLP-1, levothyroxine, metformin. Retest in 8 weeks." |
Diabetes Care, 2023 | Patients with HOMA-IR >2.5 lose 40% less weight on standard diets. GLP-1 therapy restores insulin sensitivity in 8–12 weeks regardless of calorie intake.
The Journal of Clinical Endocrinology & Metabolism, 2022 | TSH >2.5 mIU/L reduces basal metabolic rate by 10–20%, creating plateau regardless of diet. Early intervention critical.
Psychoneuroendocrinology, 2023 | Elevated cortisol (24h urine >100 µg/day) drives abdominal fat deposition independent of total calories. Sleep & stress optimization shifts fat loss to visceral deposits.
Nature Reviews Endocrinology, 2023 | Semaglutide & tirzepatide restore leptin sensitivity within 6–8 weeks. Patients transition from constant hunger to normal satiety cues.
International Journal of Obesity, 2022 | hsCRP >3.0 mg/L associated with 35% slower weight loss. Anti-inflammatory protocols double fat loss without additional calorie restriction.
Thyroid dysfunction, insulin resistance, high cortisol, and inflammation block fat loss regardless of willpower or calorie restriction.
HbA1c, fasting insulin, TSH, and cortisol are non-negotiable. One third of weight-loss failures stem from undiagnosed thyroid disease alone.
When paired with biomarker optimization, GLP-1 therapy restores leptin signaling, reduces inflammation, and fixes insulin resistance—addressing root causes, not symptoms.
HbA1c, fasting insulin, liver enzymes, and lipase must be tracked every 12 weeks to catch early markers of metabolic shift or side effects.
Weight regain happens in 80% of people who lose weight through restriction alone. Treating thyroid dysfunction, insulin resistance, and inflammation creates lasting change.
No AI chat. No templates. No copy-paste PDFs. A specialist reads your panel against South Asian-calibrated ranges and writes the protocol on a 15–20 minute video consult — inside 7 days of your home draw.